Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06456151 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Invasive Candidiasis in Critical Care

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 5, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contacts updated at 1 of 2 sitesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The combination of acute phase marker monitoring and the "T2Candida" assay (name of the test) will represent an acceleration of the identification of the causative agent of mycotic infection, a significant improvement in the specificity and positive predictive value of this strategy in the diagnosis of invasive candidiasis and candidemia in ICU patients, thereby improving the clinical condition of patients and reducing the cost of specific antifungal therapy.
Trial Details
NCT Number NCT06456151
Lead Sponsor University Hospital Ostrava
Collaborators: University Hospital, Motol
Conditions
(from sponsor)		 Invasive Candidiasis
Related terms Candidiasis, Invasive
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov